RT @victoriacyanide
From #JPM23: @GileadSciences to initiate TWO ph3 trials with #GS5245 (#obeldesivir):

OAKTREE: in standard risk patients, incl pts in the US

BIRCH: high risk pts VERSUS PLACEBO, which is already enrolling (NCT05603143)

#GS441524 prodrug! 💊

https://s29.q4cdn.com/585078350/files/doc_presentation/2023/01/GILD-JPM-Presentation-9-January-2023.pdf

RT @victoriacyanide
Nice article by @Jasonmmast contextualizing yesterday’s #VV116 data.

In article, I pointed out that an oral COVID pill (#GS441524 or prodrug) could’ve been available far earlier if they had committed & accelerated in late 2020, as their patents state 💊

https://www.statnews.com/2022/12/28/chinese-developed-alternative-to-paxlovid/